• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RHE
Click for more information
0.00% 23.5¢

RHEOCHEM PLC

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RHE
tomorrow 		22/04/11 10 1.3K
22/04/11 Last post  eer Comments Created with Sketch.  10  Views Created with Sketch.  1.3K 
RHE
Ann: Holdings in Company 		19/04/11 0 327
19/04/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  327 
RHE
Ann: Results of General Meeting 		18/04/11 0 293
18/04/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  293 
RHE
great move 		06/04/11 6 824
06/04/11 Last post  eer Comments Created with Sketch.  6  Views Created with Sketch.  824 
RHE
Ann: North Sea Farmout Agreement with PGS 		05/04/11 0 317
05/04/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  317 
RHE
Ann: Holdings in Company 		04/04/11 0 303
04/04/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  303 
RHE
private t/o bid 		03/04/11 16 1.7K
03/04/11 Last post  gold1650 Comments Created with Sketch.  16  Views Created with Sketch.  1.7K 
RHE
Ann: Holdings in Company 		01/04/11 0 319
01/04/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  319 

See All Discussions arrow Created with Sketch.

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.